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Abstract 
Mutations in the N-myc downstream-regulated gene 1 ( NDRG1 ) cause degenerative polyneuropathy in ways that are poorly understood. 
We have investigated Alaskan Malamute dogs with neuropathy caused by a missense mutation in NDRG1 . In affected animals, nerve levels 
of NDRG1 protein were reduced by more than 70% ( p < 0.03). Nerve fibers were thinly myelinated, loss of large myelinated fibers was 
pronounced and teased fiber preparations showed both demyelination and remyelination. Inclusions of filamentous material containing actin 
were present in adaxonal Schwann cell cytoplasm and Schmidt-Lanterman clefts. This condition strongly resembles the human Charcot-Marie- 
Tooth type 4D. However, the focally folded myelin with adaxonal infoldings segregating the axon found in this study are ultrastructural 
changes not described in the human disease. Furthermore, lipidomic analysis revealed a profound loss of peripheral nerve lipids. Our data 
suggest that the low levels of mutant NDRG1 is insufficient to support Schwann cells in maintaining myelin homeostasis. 
© 2020 The Author(s). Published by Elsevier B.V. 
This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 
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Degenerative neuropathies caused by mutations in N-myc 
ownstream-regulated gene 1 ( NDRG1 ) are reported from ess article under the CC BY license 
























































Overview of Alaskan Malamute dogs included in the study. 
Case number 
and sex 




Age (years) at 
sampling 
1 Female 6 1 Female 8 
2 Male 8 2 Female 11 
3 Female 3, 4, 9 3 Male 12 
4 Female 2, 6 ∗∗ 4 Male 7 
5 Female 1, 3 5 Male ∗ 13 
6 Male 2 
7 Female 1 
8 Female 1 
9 Female 2 
10 Male ∗ 5 
11 Male ∗ 2 
12 Male 1 
13 Male 6 
14 Female 6 
∗ All dogs were genotyped except case 10, case 11 and control 5, due to 
technical problems with DNA extraction from paraffin-embedded material. 
∗∗ Only muscle biopsies. 
Note: All cases except case 1 and 2 were included in [5] . Furthermore, case 





























umans, classified as Charcot-Marie-Tooth type 4D (CMT4D) 
1] , Greyhound show dogs [2] and Alaskan Malamute dogs 
3] . Cases of Alaskan Malamute polyneuropathy (AMP) were 
rst described in Norway in the 1980 ′ s [4] and the disease was 
elieved eradicated due to breeding programs, but re-emerged 
n Scandinavia several decades later [3] . AMP is inherited in 
n autosomal recessive manner and associated with a missense 
utation in NDRG1 (p.Gly98Val) [3] . Clinically, the disease 
s slowly progressive and characterized by tetraparesis, pelvic 
imb ataxia, exercise intolerance and inspiratory stridor with 
nset of clinical signs in adolescence [3-5] . 
The NDRG1 protein is not specific for peripheral nerves 
nd is detected in a wide variety of human, rodent and 
og tissues with the highest levels in epithelial cells and 
yelinating glial cells [6–8] . Still, how NDRG1 mutations 
ead to neuropathies without clinical signs from other body 
ystems, as well as the specific function of NDRG1 in 
he peripheral nervous system, are not clear [8 , 9] . The 
rotein is functionally diverse being involved in several 
ellular processes, such as vesicular transport [10–12] , 
icrotubule dynamics [13] , centrosome homeostasis [14] and 
ipid metabolism [15 , 16] . The posttranslational processing of 
DRG1 is complex and tissue- and cell-specific [7] . Notably, 
n myelinating Schwann cells high levels of phosphorylated 
DRG1 localize to the abaxonal cytoplasm and outer parts 
f the Schmidt-Lanterman clefts [7 , 17] . In addition to its 
ole in neuropathies, the NDRG1 protein is also reported 
o be involved in carcinogenesis [18] , metastasis suppression 
19] and counteracts epithelial-mesenchymal transition [20] . 
Charcot-Marie-Tooth disease (CMT) denominates the most 
requent forms of inherited neuropathies in humans. This 
s a heterogeneous group of diseases, further classified 
nto subtypes based on clinical and pathological phenotype, 
ode of inheritance, nerve conduction velocity and causative 
ene [21] . The CMT4 subgroup includes demyelinating 
europathies with autosomal recessive inheritance [22] . 
ne of them, CMT4D, also known as Hereditary motor 
nd sensory neuropathy-Lom (HMSNL), is a primary 
emyelinating neuropathy with onion bulb formation, 
ccumulation of pleomorphic material in the Schwann cell 
ytoplasm and secondary axonal loss [23] . In contrast, the 
DRG1 -associated polyneuropathy of Greyhound show dogs 
as reportedly dominated by axonal changes [2] , while 
escriptions from Alaskan Malamutes are differing [3 , 4] . 
owever, in-depth studies of nerves from affected Alaskan 
alamute dogs have not previously been performed. 
Naturally occurring neuropathies in dogs are increasingly 
ecognized as models for human neuropathies [24 , 25] . As 
pposed to experimental rodents, dogs naturally develop 
imilar diseases to humans. Dogs also have a larger body 
ize and a life-expectancy that is more comparable to this 
pecies. Furthermore, dogs share environmental conditions 
nd lifestyle with humans. Together this makes them excellent 
ranslational disease models [2] . The fact that dogs can be 
nvestigated with sophisticated standardized neurological and 
lectrophysiological tests is a further advantage, as it allows 
or a detailed characterization of the disease phenotype . 57 The aim of this study was to describe in detail the 
orphology of AMP nerves and discuss these changes in 
elation to the cell biology of NDRG1 and the overall clinical 
resentation. Furthermore, studying Alaskan Malamutes with 
 NDRG1 mutation is relevant to understand more about the 
nvolvement of NDRG1 in human diseases. 
. Materials and methods 
.1. Animals 
Nineteen privately owned pure-bred Alaskan Malamute 
ogs (14 affected dogs and 5 controls free from clinical 
igns of polyneuropathy) were included in the study ( Table 1 , 
etailed information in Suppl. Table A.1. Number of dogs 
nalyzed with the methods and age of depicted animals 
re also provided in the figure legends). Sixteen out of 
ineteen were genotyped for the NDRG1 -allele using the 
reviously described TaqMan assay [3] ; Twelve dogs ( n = 12) 
ere classified as homozygous mutants (mut/mut) and four 
ogs were homozygous wild type (wt/wt) ( n = 4). Whether 
enotyped or not, all affected dogs ( n = 14) were closely 
elated to each other and presented with neurological signs 
lassically associated with AMP. All samples for the study 
ere collected by veterinarians after written consent from 
he dog owners. No ethics committee approval was required 
s all samples were taken as part of the standard diagnostic 
rocedures, in vivo ( n = 7) and/or postmortem ( n = 15), and 
he investigation did not interfere or impede other tests. 
nformation regarding sex, age at sampling, results from 
lectrodiagnostic testing (electromyography (EMG) and motor 
erve conduction velocity (MNCV)), and clinical course was 
ollected from the medical records. 


























































































.2. Tissue sampling 
Biopsies from the common fibular nerve and the cranial 
ibial, biceps femoris and gastrocnemius muscles were taken 
nder general anesthesia as part of the diagnostic workup. 
ormalin-fixed and fresh samples from both nerve and 
uscles were shipped by courier to diagnostic laboratories 
or evaluation. Fixed nerve biopsies were resin-embedded and 
valuated in semithin sections (1 μm), while fixed muscle 
iopsies were paraffin-embedded and routinely stained with 
ematoxylin and eosin. Unfixed biopsies were transported on 
old packs and evaluated cryohistologically with a standard 
anel of histochemical stains and reactions [26] . 
Postmortem examinations were carried out shortly after 
entobarbital-euthanasia. Samples for immunohistochemistry 
nd immunofluorescence were fixed in 10% buffered formalin 
nd subsequently paraffin-embedded. Samples for Western 
lotting and RT-qPCR were snap frozen in isopentane, 
ransferred to liquid nitrogen and stored at −80 °C until 
nalysis. Samples for electron microscopy and nerve fiber 
easing were gently separated into individual fascicles and 
xed in 2.5% glutaraldehyde in Sorensen’s phosphate buffer 
0.1 M, pH 7.4) for 4 h at room temperature. For details about 
ampled nerves from individual dogs see Suppl. Table A.1. In 
ddition, a routine postmortem examination was performed, 
ncluding sampling from cranial tibial, biceps femoris and 
astrocnemius muscles. 
.3. Western blotting 
Nerve samples from four NDRG1 mut/mut and four 
DRG1 wt/wt Alaskan Malamutes were thawed, and the 
pineurial fat removed. Western blotting was performed 
s previously described [7] . Protein transfer efficiency and 
rotein loading were assessed by staining total protein on 
he PVDF membranes by SYPRO R © Ruby Protein Blot 
tain (Molecular Probes, Thermo Fisher Scientific). Band 
ignals were quantified with ImageQuant TL (GE Healthcare) 
nd statistical analyses performed with a non-parametric 
est (Mann Whitney U-test) in GraphPad Prism (GraphPad 
oftware, San Diego, California, USA). 
.4. RT-qPCR 
Nerve tissue from four NDRG1 mut/mut and four NDRG1 wt/wt 
laskan Malamutes was homogenized in Trizol (Thermo 
isher Scientific) using a Mixer mill 301 (Retsch, Haan, 
ermany). Following the Trizol extraction, total RNA 
as further purified with Rneasy Plus minikit (Qiagen). 
DNA was synthesized using SuperScript III Reverse 
ranscriptase, RNase Out, dNTP mix and Random Primers 
all from Invitrogen, Thermo Fisher Scientific). qPCR 
as performed with LightCycler 480 Sybr Green I 
aster mix (Roche) and cDNA corresponding to 2.5 ng 
NA. The following primers were used: caNDRG1-F2 
TGAACAACCCCGAGATGGTG), caNDRG1-R2 (CCCGG 
GATCTTGGATGCAG), caGAPDH-1F (GTATGATTCTA 58 CCACGGCAAAT) and caGAPDH-1R (GATGGACTTCCC 
TTGATGACAA). Samples were run in quadruplets in a 
otal volume of 20 μl. The LightCycler 96 System (Roche) 
as run under the following conditions; 5 min at 95 °C, 40 
ycles of 10 s at 95 °C, 10 s at 60 °C, and then 10 s at 72 °C;
nd melting curve with 5 s at 95 °C, 1 min at 65 °C and 97 °C.
Statistics (Mann Whitney U-test) were performed in 
raphPad Prism. 
.5. Processing for transmission electron microscopy and 
erve fiber teasing 
Processing for transmission electron microscopy and nerve 
ber teasing were performed as previously described [27] . 
.6. Antibodies 
Details about the antibodies used in the different analyses 
re specified in Table 2 . 
.7. Immunofluorescence and immunohistochemistry 
Sections of 3–4 μm from formalin-fixed and paraffin- 
mbedded tissues were placed on glass slides (Superfrost 
lus R ©, Menzel Gläser, Thermo Fisher Scientific) and stored at 
 °C until staining. Previously described protocols were used 
or immunofluorescence [7] and immunohistochemistry [27] . 
.8. Morphometry 
Images from semithin sections of n. fibularis communis 
 n = 8) or n. tibialis ( n = 3) were evaluated by Image-
ro Plus (Media Cybernetics, Rockville, Maryland, USA). 
he area of the nerve fibers and axons were measured. 
hereafter, the diameters of these were derived from the 
rea of a circle of equivalent area [28] , and the g-ratios 
alculated. Statistics (Mann Whitney U-test) were performed 
n GraphPad Prism. An example of the image analysis is 
rovided in Supplementary Fig 1. 
.9. Extraction and analysis of lipids from peripheral 
erves 
Lipid extraction from nerves and non-targeted lipid 
nalysis were performed as previously described [27] . Briefly, 
nap frozen nerve tissue (50 mg) was homogenized with a 
ead homogenizer and lipids were extracted using mixture 
f chloroform and methanol. The lipid analysis was carried 
ut using the supercritical fluid chromatographic system 
cquity UPC2 R © coupled to a quadrupole time-of-flight mass 
pectrometer SYNAPT G2-S HDMS (both Waters, Milford, 
assachusetts, USA). The method used allows detection of 
G, DG, MG, Cer, HexCer, HexCer(OH), SM, FC, CE, PG, 
C, LPC, PE and LPE. Non-targeted data were processed with 
rogenesis QI enabling export of list of compounds found 
long with their abundances. Data were further filtered using 
n in-house developed script collecting total abundances for 
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Table 2 
Antibodies and dilutions used in the analyses. 
Name Catalog number Producer Dilutions 
IF IHC WB 
Anti-NDRG1 WH0010397 Sigma-Aldrich, Merck, Darmstadt, Germany 1/2000 NA 1/2000 
Phospho-specific 
anti-NDRG1 (Thr346) 
5482 Cell Signaling Technology, Leiden, Netherlands NA NA 1/1000 
Anti-neurofilament 200 064H-4809 (batch 
number) 
Sigma-Aldrich, Merck, Darmstadt, Germany 1/400 NA NA 
Anti-beta actin MA1–140 Invitrogen, Thermo Fisher Scientific, 
Massachusetts, USA 
1/2000 NA NA 
Anti-CD3 A-0452 Dako, California, USA NA 1/500 NA 
Anti-CD79 NB100–64,347 Novus Biologicals, Colorado, USA NA 1/750 NA 
Anti-Iba1 019–19,741 Fujifilm Wako Chemicals, Neuss, Germany NA 1/250 NA 








































































ach individual lipid class. Response factors (Rf) were used 
or correction of raw abundances to show semi-quantitative 
omposition of lipid classes in the studied samples. Rf 
ere determined experimentally by comparing abundances of 
ipid standards, one representative per each class, of equal 
oncentration. Two-tailed independent t -test was performed 
o evaluate statistical difference in lipid class distribution 
etween the groups. 
. Results 
.1. Long-term clinical course and electrodiagnostic 
xamination 
Four of the 14 affected dogs were euthanized, at the 
wner’s request, in conjunction with the diagnosis of AMP. 
en of the affected dogs were allowed to survive this 
isease stage and followed up (median 44 months, range 
2–100 months) by repeated examinations or contact with 
linicians in the research group. In three of these 10 dogs, 
he clinical signs gradually progressed until euthanasia. In 
ne other dog, the clinical signs progressed in the two years 
ollowing diagnosis, but the dog was subsequently lost to 
ollow up. In the remaining six dogs followed up, both the gait 
bnormalities and the exercise intolerance slowly improved 
uring the months after nadir and then stabilized. However, 
one of the dogs returned to normal and the inspiratory stridor 
ersisted. At a later stage (at the age of 3 and 6 years, 
espectively), two affected dogs presented with regurgitation 
ue to development of megaoesophagus (Suppl. Fig. 2 ) and 
ere then euthanized. Eleven of the 14 affected dogs were 
ubjected to postmortem examination and autopsy confirmed 
egaoesophagus in three dogs (including the two dogs with 
egurgitation). 
MNCV in the fibular ( n = 4, mean 23.13 m/s, SD 14.24, 
eference 79.8 ±1.9 [29] ) and ulnar nerves ( n = 10, mean 
7.5 m/s, SD 12.73, reference 58.9 ±1 [29] ) were decreased 
n all the examined dogs (Suppl. Table 1 ). In two dogs, 
NCV could not be determined as no compound muscle 
ction potential (CMAP) was produced by stimulation. EMG 
evealed spontaneous activity in several muscles in all dogs 59 ested ( n = 10). In two dogs, repeated MNCV measurements 
ere performed. For case three, the MNCV in the ulnar nerve 
as 30, 40 and 56.3 m/s at the age of three, eight and nine 
ears, respectively. Furthermore, the MNCV in the fibular 
erve was 31.4 m/s at the age of three years, but not possible 
o measure at the age of nine. For case four, the MNCV in 
he fibular nerve was 29 m/s and 26.9 m/s at the age of two
nd five years, respectively. 
.2. Levels of NDRG1 protein and mRNA 
Nerves from affected dogs had reduced NDRG1 protein 
evels compared to controls ( Figs. 1 A, C). The intensity of 
he 42 kDa band, corresponding to the full length protein, 
s well as the bands with molecular weights between 
2 and 40 kDa, were reduced by approximately 70% in 
he NDRG1 mut/mut dogs ( p = 0.029). Additionally, there was 
 significant reduction in signal intensity from the band 
orresponding to NDRG1 phosphorylated at residue Thr346 
pNDRG1) in this group of dogs ( p = 0.029, Figs. 1 B, C).
n contrast, the mRNA levels in nerves of NDRG1 mut/mut 
ogs normalized to GAPDH were not significantly different 
rom the controls ( p = 0.2, Fig. 1 D). It should be noted that
APDH has not been validated as a reference gene for mRNA 
xpression analysis in nerves of dogs, thus the result should 
e interpreted with caution. 
.3. Pathology 
.3.1. Teased nerve fibers 
In nerves from affected dogs examined by nerve fiber 
easing, internodal lengths and myelin thickness varied 
 Fig. 2 ). Demyelinated segments and short internodes with 
educed myelin thickness (intercalated internodes), consistent 
ith remyelination, were present. The changes had a 
ultifocal distribution, and severely affected internodes 
ntermingled with internodes without observable changes. 
his distribution is typical for a demyelinating disease 
30 , 31] . In some cases, paranodal retraction and widening 
f the nodal gap were evident. Focal thickenings of the 
erve fibers were present, mostly internodally, occasionally 
F.S. Skedsmo, A. Espenes, M.A. Tranulis et al. Neuromuscular Disorders 31 (2021) 56–68 
Fig. 1. A, B. Western blot of nerve lysate from Alaskan Malamute controls ( n = 4) and cases ( n = 4) with antibodies against NDRG1 ( A ) and phospho-NDRG1 
( B ). C. Semiquantification of NDRG1 protein in nerve lysates based on band intensity in Western blot (mean + SD). There is a significant reduction in the levels 
of both total NDRG1 ( p = 0.029) and pNDRG1 ( p = 0.029) in NDRG1 mut/mut Alaskan Malamutes compared to controls. D. Relative expression of NDRG1 
mRNA in nerve samples (mean + SD) from Alaskan Malamutes controls ( n = 4) and cases ( n = 4). Relative expression levels were calculated using the Relative 
Standard Curve method with standard curves obtained from a random sample, and NDRG1 expression was normalized to GAPDH . The difference between 




























lose to the Schwann cell perikaryon ( Fig. 2 d), but paranodal 
ocalization was also observed. At this level, it was not 
ossible to ascertain whether the swellings derived from 
he axon, the Schwann cell or both. Wallerian-like axonal 
egeneration was observed in only a few fibers (not shown). 
.3.2. Light microscopy 
Nerves from NDRG1 mut/mut Alaskan Malamutes exhibited 
 loss of large myelinated fibers ( Fig. 3 A) accompanied 
y a concurrent increase in endoneurial connective tissue. 
hese changes varied inter- and intraindividually from only 
ild affection to severe loss of fibers with concomitant 
brosis. As shown morphometrically for the common fibular 
erve, there was a shift in the distribution of myelinated 
erve fibers towards smaller diameter fibers ( Fig. 3 B). As 60 he same shift was observed in axonal diameter-frequency 
istograms, this shift is probably caused by a combination of 
oss of large myelinated fibers and reduced myelin thickness. 
hile the fibular nerves from the NDRG1 wt/wt Alaskan 
alamutes had the expected bimodal diameter distribution 
f myelinated fibers [32] , the distribution in nerves from 
ome of the cases approached unimodality (for example case 
our). For case three and five, biopsies taken at different 
ges allowed assessment of a potential disease progression. 
he investigations showed a shift towards thinner fibers at 
reater age. The myelinated fiber density was not significantly 
ifferent between the groups ( p = 0.1429. Controls: n = 2, 
ean: 4798.2 MF per mm 2 , SD 959.2. Cases: n = 6, mean: 
058.9 MF per mm 2 , SD 1021.4). 
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Fig. 2. Teased nerve fibers, representative examples from controls ( a , n = 2) and cases ( b-f , n = 4). Boxes indicated by roman numerals are magnified in the 
lower part of the figure. In fibers from cases, paranodal ( b , magnified in I ) and segmental demyelination ( c ) were present. Focal thickenings of the nerve fiber 
were observed internodally ( d , e , magnified in II ), occasionally close to the Schwann cell nucleus ( d , white arrow). Short and thinly myelinated internodes, 
consistent with remyelination, intermingled with longer internodes with thicker myelin sheath ( d-f , magnified in III ). Nodes of Ranvier are indicated by black 
arrows. DeM = Demyelinated segment. ReM = Remyelinated segment. Bar 200 μm. Origin of depicted fibers and age at sampling: Control 2 (11 years old, a ), 























When nerves were studied at higher magnification, many 
f the remaining fibers had thin myelin sheaths in relation 
o the axonal size ( Figs. 4 E-G), in agreement with results 
rom the study of teased fibers and our finding that the g- 
atios of the NDRG1 mut/mut Alaskan Malamutes were shifted 
owards higher values compared to the control (Suppl. Fig. 3 ). 
resumptive regenerative clusters were observed in some of 
he nerves ( Fig. 4 E). Swollen nerve fibers were present in the 
erves from the NDRG1 mut/mut Alaskan Malamutes ( Figs. 4 F, 
) and studied more closely at the ultrastructural level (see 
ection 3.3.3 ). 
Lesions were observed in both proximal (for example 
erve roots and sciatic nerves) and distal nerve segments 61 such as tibial, fibular and recurrent laryngeal nerves), long 
for example recurrent laryngeal nerve) and short nerves 
obturator nerve), and involved both mixed and purely sensory 
erves (superficial radial nerve). 
In skeletal muscle, angular atrophy of myofibers (varying 
rom scattered singular to small and large groups) were 
resent ( Fig. 4 A), in accordance with denervation atrophy 
ollowing axonal loss. The angular atrophied fibers were 
f both fiber types as shown by the ATPase reaction 
 Fig. 4 B). The normal mosaic pattern of muscle fiber types 
as regionally absent in some cases with fiber type grouping, 
upporting attempts at reinnervation ( Fig. 4 B). 
F.S. Skedsmo, A. Espenes, M.A. Tranulis et al. Neuromuscular Disorders 31 (2021) 56–68 
Fig. 3. Semithin sections (A) and myelinated fiber diameter-frequency histograms (B) from the common fibular nerve of controls ( n = 2) and cases ( n = 6). 
A . Note the reduction of large myelinated fibres in the cases. The prominent Renaut bodies observed in case 4 are not typical findings in affected dogs. Bar 
100 μm. B . There is a shift in the distribution of myelinated fibres in the cases. For case 3 and 5, morphometrical comparison of biopsies taken at different 
ages is included in the histogram. Y -axis: Percentage of myelinated fibers. X -axis: Diameter of myelinated fibers in μm. Age at sampling: Control 2 (11 years 
old), control 3 (12 yo), case 3 (3, 4, 9 yo), case 4 (2 yo), case 5 (1, 3 yo), case 6 (2 yo), case 7 (1 yo), case 8 (1 yo). 
62 
F.S. Skedsmo, A. Espenes, M.A. Tranulis et al. Neuromuscular Disorders 31 (2021) 56–68 
Fig. 4. Representative light micrographs of skeletal muscle ( A, B ) and nerves ( C–G ) from affected ( A, B, E–G , n = 8) and control ( C, D , n = 3) Alaskan 
Malamutes. A . Scattered and small groups of angular, atrophic myofibers (arrows) in the gastrocnemius muscle (case 3, 9 years old). B . Fiber type grouping 
in the gastrocnemius muscle (case 5, 1 yo). Type 1 muscle fibers are dark, while type 2 are pale. C, D . Nerve from a control Alaskan Malamute (control 1, 
6 yo). E . Axonal loss and thinly myelinated (remyelinating) fibers in nerve from affected Alaskan Malamute (case 2, 8 yo). A presumptive regenerative fiber 
cluster is indicated by red arrow. F, G . Focal swelling of nerve fibers (red arrows) is seen in both longitudinal ( F ) and transverse ( G ) sections (case 1, 6 yo). 
A myelinated fiber with very thin myelin sheath is highlighted (box and inset) in G . Stained with hematoxylin and eosin ( A ), Myofibrillar ATPase reaction 
at pH 4.3 ( B ), toluidine ( C–E ), toluidine and safranin-O ( F, G ). 
63 






















































Relative lipid class distribution in peripheral nerves from Alaskan Malamute 
polyneuropathy cases ( NDRG1 mut/mut ) and controls ( NDRG1 wt/wt ). 
Lipid class NDRG1 wt/wt ( n = 3) NDRG1 mut/mut ( n = 3) t -test 
Mean% SD Mean% SD P -value 
MG 0.79 0.5 0.88 0.8 0.83521 
DG 2.29 0.7 1.97 1.1 0.63792 
TG 55.31 11.5 78.01 12.4 0.06677 
HexCer 3.70 1.3 0.99 0.5 0.03254 
HexCer(OH) 1.33 0.4 0.37 0.2 0.02726 
CE 2.85 1.6 5.53 4.8 0.29980 
PC 6.31 1.5 3.30 1.4 0.06620 
FC 0.20 0.1 0.09 0.1 0.07106 
SM 21.73 4.8 5.99 3.0 0.00943 
LPC 0.05 0.0 0.06 0.0 0.68876 
PE 5.43 1.7 2.81 1.7 0.10401 
MG = Monoacylglycerols, DG = Diacylglycerols, TG = Triacylglycerols, 
HexCer = Hexosylceramides, CE = Cholesteryl esters, PC 
= Phosphatidylcholines, FC = Free Cholesterol, SM = Sphingomyelins, 






























.3.3. Ultrastructural pathology 
The ultrastructural examination confirmed the presence 
f thinly myelinated nerve fibers and small onion bulbs 
not shown). Onion bulbs and thinly myelinated nerve 
bers suggest repeated episodes of demyelination and 
emyelination. Macrophages with intracytoplasmic vacuoles 
ere present around demyelinated nerve fibers and also 
bserved intratubary (not shown). The presence of Iba1 + - 
acrophages in the endoneurium was confirmed by 
mmunohistochemistry (see Section 3.3.5 ). 
A frequent finding was accumulation of filamentous 
aterial in the cytoplasm of myelinating Schwann cells. 
his material was observed in the adaxonal Schwann cell 
ytoplasm or in the inner part of dilated Schmidt-Lanterman 
lefts ( Figs. 5 A). Occasionally, the Schmidt-Lanterman clefts 
ere disrupted and then associated with dyscompacted 
yelin sheaths mixed with a pleomorphic, coarsely granular 
smiophilic material ( Figs. 5 B, C) dispersed between the 
heets. This morphologically heterogenous material probably 
onsists of a mixture of the aforementioned filamentous 
aterial and lipids from myelin degradation as it intermingled 
ith fragments of periodically structured lamellae [33] . 
Focally folded myelin was often observed consisting of 
nfoldings derived from the inner part of the myelin sheaths 
 Figs. 5 D, E, F). The folds evolved from the Schmidt- 
anterman clefts ( Fig. 5 D) and occasionally seemed to 
ubdivide the axon into pockets ( Fig. 5 E, F). This resulted in 
everal axonal structures enclosed by the same myelin sheath, 
eparated by thin myelin septa derived from the adaxonal 
art of the sheath ( Figs. 5 B, D–F). Degenerating organelles 
ere present in the myelin-enclosed axonal pockets ( Figs. 5 B, 
–F), suggestive of disrupted axonal transport and early 
xonal degeneration. Despite an overall increase in nerve fiber 
iameter, the diameter of the axon was often reduced and the 
xonal outline distorted in the segments with focally folded 
yelin, seemingly compressed by the myelin infoldings and 
daxonal Schwann cell material ( Figs. 5 B, E). Artefactual 
hanges can be produced by delayed fixation, however, as 
he ultrastructural changes reported were also present in nerve 
iopsies fixed immediately after surgical removal, we consider 
t unlikely that the reported changes are artefacts. 
.3.4. Immunofluorescence 
As structures resembling Hirano bodies, containing actin 
nd actin-related proteins [34] , have been described in the 
chwann cell cytoplasm of rodents with Ndrg1 mutations [9] , 
mmunofluorescence was performed with antibodies against 
-actin and neurofilament. In nerves from the NDRG1 mut/mut 
laskan Malamutes, β-actin-positive aggregates were present 
ultifocally in myelinating Schwann cells ( Fig. 6 , Suppl. 
ig. 4 ). More specifically, the β-actin signal was present in 
hin strands and occasionally formed circular or semi-circular 
tructures. The diameter of the neurofilament-positive axon 
as reduced in these areas, but axonal swellings were present 
n adjacent segments. Occasionally, the actin-positive material 
urrounded small axonal structures only coupled to the main 
xonal structure through thin connections. 64 .3.5. Immunohistochemistry 
Infiltration and/or proliferation of macrophages, T- and B- 
ymphocytes in the nerves were investigated with antibodies 
gainst Iba1, CD3 and CD79, respectively. While increased 
umbers of Iba1 + cells in the endoneurium were observed in 
DRG1 mut/mut Alaskan Malamutes compared to NDRG1 wt/wt , 
o difference between the genotypes was observed for CD3 
nd CD79 (not shown). 
.4. Lipid analysis 
Analysis of peripheral nerve lipid composition revealed 
ignificant decreases in hexosylceramides (HexCer) and 
phingomyelins (SM) in the relative lipid class distribution 
n the NDRG1 mut/mut Alaskan Malamutes compared to 
DRG1 wt/wt (Suppl. Fig. 5 and Table 3 ). 
. Discussion 
Neuropathies can be caused by malfunctions at either end 
f the axo-glial communication axis; i.e., be primary axonal or 
rimary glial cell disorders. This distinction is important for 
nderstanding the etiology and molecular pathology of a given 
isease, but can be difficult to ascertain due to overlapping 
linical and pathological features, regardless of the primary 
efect [35–37] . Since NDRG1 is expressed in Schwann cells 
nd not axons, polyneuropathies associated with mutations in 
DRG1 are expected to result from compromised Schwann 
ell functions. In accordance with this, human CMT4D 
atients show demyelinating changes in childhood, rapidly 
ollowed by axonal loss [9 , 38] and severe clinical signs 
38 , 39] . In mice models of this disease, demyelination is 
he dominant feature, with less pronounced axonal loss [9] . 
n this report, we provide a detailed characterization of 
he NDRG1 -associated Alaskan Malamute polyneuropathy, 
evealing previously unrecognized features. 
F.S. Skedsmo, A. Espenes, M.A. Tranulis et al. Neuromuscular Disorders 31 (2021) 56–68 
Fig. 5. Electron micrographs of nerves from affected Alaskan Malamutes ( n = 8), transverse (A-D) and longitudinal (E, F) sections. A . Accumulation of 
filamentous material in the inner part of distended Schmidt-Lanterman clefts. B, C. Disrupted Schmidt-Lanterman cleft (arrow in B, white box magnified in C ) 
with coarsely granular material (asterisk in C ) between dyscompacted myelin lamellae from the inner part of the myelin sheath. Note the two axonal structures 
within the myelin sheath in B , both with aggregates of mitochondria. D, E, F. Infoldings of the myelin sheath, originating from a Schmidt-Lanterman cleft 
( D ), seemingly dividing the axon into several structures. The axonal cytoplasm contains accumulated organelles, including degenerating mitochondria ( D-F ) 
and aggregates of neurofilaments (black frame in D , magnified in inset), consistent with early axonal degeneration. The focal distribution of changes are shown 
in E (white frame magnified in F ). Arrow ( F ) indicate dyscompacted myelin. Origin of electron micrographs and age at sampling: Case 1 (6 years old, A ), 
case 3 (9 yo, B , C , E , F ), case 2 (8 yo, D ). 
65 
F.S. Skedsmo, A. Espenes, M.A. Tranulis et al. Neuromuscular Disorders 31 (2021) 56–68 
Fig. 6. Immunofluorescence on nerve sections (cases n = 3, controls n = 2). Representative images from case 5 (3 years old) with antibodies against beta-actin 
(green) and neurofilament (red), two different nerve fibers are shown. Nuclei are stained with DAPI (blue). Aggregates of actin are present in the nerves of 
affected Alaskan Malamutes. Note the difference between the aggregates and the sparse amount of actin normally present in the Schmidt-Lanterman clefts 
(arrowheads). Although the axonal diameter was reduced in the areas with aggregates, the axon was swollen adjacent to these segments (asterisk). Note the 











































































The changes observed in the nerves of affected Alaskan 
alamutes in this study indicate a demyelinating disease with 
emyelination, characteristic axonal changes and eventually 
oss. Thus, Alaskan Malamutes with NDRG1 mutations 
re apparently more similar to humans with CMT4D than 
he rodent models where axonal involvement is milder 
9 , 23 , 39 , 40] . Our findings contrast with previous reports from
ogs [2 , 3] . In a study of Greyhounds lacking NDRG1 [2] ,
nd in a previous report on the same AMP as presented 
ere [3] , it was concluded that the disease was predominantly 
xonal or mixed due to the presence of degenerative axonal 
hanges in segments without concurrent myelin abnormalities. 
n the Greyhounds, thinly myelinated (i.e. remyelinated) nerve 
bers, dyscompaction of the adaxonal myelin sheath and 
ranulofilamentous inclusions in the Schwann cell cytoplasm 
ere also observed [2] . Thus, the changes in nerves of 
umans, rodents and dogs with NDRG1 abnormalities share 
ertain similarities, and AMP is indeed a new model for 
uman CMT4D, replicating both the demyelination and 
xonal changes, in both motor and sensory nerve fibers, 
resent in the human disease [23 , 40] . 
A progressive polyneuropathy is described in human 
MT4D patients with gait disturbance in their first decade, 
pper limb involvement in their second and sensorineural 
eafness in their third decade of life [38] . Disease 
rogression in affected Alaskan Malamutes was documented 
ith the diameter shift observed in morphometric analyses 
f semi-thin nerve sections from a few dogs. Results 
rom electrodiagnostic examinations were in agreement with 
 polyneuropathy involving motor nerve fibers, but in 
ase 3, serial measurements revealed improved MNCV 
ith increasing age - in accordance with her clinical 
evelopment during adulthood. The observed increase in 
NCV is in accordance with remyelination of previously 
emyelinated internodes, through which the nerve conduction 
elocity might recover to at least 60% of normal [41] . 
he remyelinated internodes remain thinner than normal, 
xplaining the reduction in myelinated fiber diameter 
bserved by morphometry in the same dog. 66 The filamentous material present in the adaxonal cytoplasm 
nd inner part of the Schmidt-Lanterman cleft resembles 
nclusion material reported from the same location in nerves 
f human CMT4D patients and rodent models of this disease 
9 , 23 , 39 , 40] . In humans with CMT, this material is seemingly
pecific for the 4D subtype [40 , 42] , however, to the best 
f our knowledge, the content of the material has not 
een ascertained. From studies in rodents, the inclusions 
ave been proposed to represent Hirano bodies based on 
orphological criteria [9] , but in human CMT4D nerves, 
 similar material did not have the structured morphology 
f true Hirano bodies [23] . Hirano bodies are described 
s paracrystalline inclusions consisting of sheets of parallel 
ctin filaments [34] . The filamentous material observed 
n the nerves of affected Alaskan Malamutes lacked the 
aracrystalline structure reported from rodents [9 , 43] , but 
therwise resembles the inclusion material reported from 
umans and rodents by its ultrastructural morphology and 
ocalization. Furthermore, we confirm its richness in actin by 
mmunofluorescence. 
Actin polymerization occurs in Schwann cells in both 
ealth and disease. Actin remodelling drives the membrane 
xtension during normal myelination [44] as well as in 
onditions with excessive myelin growth [45] . Furthermore, 
ctin polymerization occurs in Schmidt-Lanterman clefts 
uring Wallerian degeneration [46] , and recently, signaling 
rom injured axons were shown to trigger formation of 
onstricting actin spheres in Schwann cells, important 
or swift removal of the degenerating axon [47] . Actin 
olymerization was also found in the Schmidt-Lanterman 
lefts and adaxonal Schwann cell cytoplasm of Tibetan 
astiffs with Inherited Hypertrophic Neuropathy, where the 
laments ultimately caused distension of the Schwann cell 
ytoplasm and subdivision of the axon [31 , 48 , 49] , strongly 
esembling the apparent division of the axon regionally within 
ne myelin sheath observed in the AMP nerves. This change 
s also described from Greyhounds lacking NDRG1 [2] , but 
ot reported in CMT4D [9 , 23 , 39 , 40 , 50–52] . It remains to
nvestigate the relationship between NDRG1 functions and 










































































[  ctin polymerization in Schwann cells and the possible role 
f filaments in the intrusion of the Schwann cell into the 
xon. The intrusions with myelin infoldings could represent 
ocal hypermyelination, caused by reduced NDRG1 activity 
n Schwann cells, and the actin aggregates observed in the 
chmidt-Lanterman clefts of AMP nerves could conceivably 
e an early stage in the uncontrolled membrane growth 
ltimately leading to formation of myelin folds [45] and 
xonal degeneration. 
We have previously shown that phosphorylated NDRG1 
referentially localized to the abaxonal cytoplasm and outer 
spects of the Schmidt-Lanterman clefts in myelinating 
chwann cells of normal dogs by immunofluorescence, while 
o pNDRG1 signal was observed in an affected Alaskan 
alamute [7] . Phosphorylated NDRG1 (Thr346) has been 
uggested to participate in termination of myelination, as 
oss of serum glucocorticoid kinase 1 (Sgk1), with less 
NDRG1 as a sequel, caused hypermyelination in mice [17] . 
e did not observe decreased g-ratios in the NDRG1 mut/mut 
laskan Malamutes, as would be expected in a condition with 
iffuse hypermyelination. However, in conditions with focal 
ypermyelination, a reduced g-ratio may not be found [53] , 
s most cross-sections of nerves with focally folded myelin 
ill be represented in a semithin section by a nerve segment 
ith normal myelination. Further studies are needed to 
nvestigate whether the NDRG1 mutation disrupts signalling 
n the Schwann cells by affecting the phosphorylation of the 
ncoded protein, either directly or indirectly. 
Analysis of peripheral nerve lipid composition revealed 
everal differences between the genotype groups. Loss of 
DRG1 function can conceivably affect lipid composition 
f the nerves directly, as NDRG1 participated in vesicular 
ecycling of the low-density lipoprotein receptor (LDLR) in 
pithelial cells [12] and regulated lipid metabolism in breast 
ancer cells [16] . In the latter, silencing of NDRG1 resulted in 
ncreased triacylglycerol levels. However, unspecific changes 
aused by loss of myelin and axons in the AMP nerves 
recludes interpretation of changes specifically related to 
oss of NDRG1 function. These include for example the 
bserved significant reduction in the levels of sphingomyelins 
nd glycolipids [54] . Thus, a specific contribution to the 
bserved differences in lipid composition from loss of 
DRG1 function cannot be ruled out, but needs further 
nvestigation. 
The Western blots showed that the nerve levels of 
DRG1 in the affected Alaskan Malamutes were significantly 
educed, but not completely lost. In contrast, Greyhounds 
ith NDRG1 -associated neuropathy were reported to have a 
otal NDRG1-deficiency [2] , just as in humans with CMT4D 
aused by a nonsense mutation [9] . The incomplete loss of 
DRG1 function in the Alaskan malamutes results in a later 
nset and milder clinical course of AMP as compared with the 
europathies in Greyhounds and the stretcher mouse model 
9] in which there is complete loss of NDRG1. 
In conclusion, Alaskan Malamutes with NDRG1 mutations 
s a unique spontaneous model, which demonstrates 67 orphological features resembling the human CMT4D, but 
lso reveals some previously undescribed changes. 
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